PiRNAs warrant investigation in Rett Syndrome: An omics perspective

Disease Markers

Volumn 33, Issue 5, 2012, Pages 261-275

  Saxena, Alka ^a   Tang, Dave ^a   Carninci, Piero ^a  

^a RIKEN   (Japan)

Author keywords

LINE 1; MeCP2; piRNAs; Rett Syndrome; short RNAs

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; METHYL CPG BINDING PROTEIN 2; PIWI INTERACTING RNA;

BIOGENESIS; CEREBELLUM; DNA BINDING; DNA METHYLATION; DNA MODIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROPOSON; RETT SYNDROME; REVIEW; TRANSCRIPTION REGULATION; TRANSPOSON;

EID: 84872353105     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2012/396737     Document Type: Review

References (54)

1. Amir, R.E., et al., Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet, 1999. 23(2): 185-8.
2. Weaving, L.S., et al., Mutations of CDKL5 cause a severe neurodevelopmental disorderwith infantile spasms andmental retardation. Am J Hum Genet, 2004. 75(6): 1079-93.
3. Ariani, F., et al., FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet, 2008. 83(1): 89-93.
4. Neul, J.L., et al., Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol, 2010. 68(6): 944-50.
5. Adler, D.A., et al., The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse. Mamm Genome, 1995. 6(8): p. 491-2.
6. Chaumeil, J., et al., A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev, 2006. 20(16): 2223-37.
7. Carrel, L. and H.F. Willard, X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature, 2005. 434(7031): 400-4.
8. Lingenfelter, P.A., et al., Escape fromXinactivation of Smcx is preceded by silencing during mouse development. Nat Genet, 1998. 18(3): 212-3.
9. Xu, J., X. Deng and C.M. Disteche, Sex-specific expression of the X-linked histone demethylase gene Jarid1c in brain. PLoS One, 2008. 3(7): e2553.
10. Yang, F., et al., Global survey of escape from X inactivation by RNA-sequencing in mouse. Genome Res, 2010. 20(5): 614-22.
11. Hoffbuhr, K.C., et al., Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev, 2002. 8(2): 99-105.
12. Weaving, L.S., et al., Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A, 2003. 118A(2): 103-14.
13. Huppke, P., et al., Very mild cases of Rett syndrome with skewed X inactivation. J Med Genet, 2006. 43(10): 814-6.
14. Xinhua, B., et al., X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. J Child Neurol, 2008. 23(1): 22-5.
15. Kriaucionis, S. and A. Bird, The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res, 2004. 32(5): 1818-23.
16. Mnatzakanian, G.N., et al., A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet, 2004. 36(4): 339-41.
17. Saxena, A., et al., Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2. J Med Genet, 2006. 43(6): 470-7.
18. Gianakopoulos, P.J., et al., Mutations in MECP2 exon 1 in classical Rett patients disruptMECP2 e1 transcription, but not transcription of MECP2 e2. Am JMed Genet B Neuropsychiatr Genet, 2012. 159B(2): 210-6.
19. Nan, X., et al., Transcriptional repression by the methyl-CpGbinding protein MeCP2 involves a histone deacetylase complex. Nature, 1998. 393(6683): 386-9.
20. Jones, P.L., et al.,Methylated DNAand MeCP2 recruit histone deacetylase to repress transcription. Nat Genet, 1998. 19(2): 187-91.
21. Georgel, P.T., et al., Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem, 2003. 278(34): 32181-8.
22. Nikitina, T., et al., Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol, 2007. 27(3): 864-77.
23. Shahbazian, M., et al., Mice with truncated MeCP2 recapitulatemany Rett syndrome features and display hyperacetylation of histone H3. Neuron, 2002. 35(2): 243-54.
24. Skene, P.J., et al., Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell, 2010. 37(4): 457-68.
25. Yasui, D.H., et al., Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA, 2007. 104(49): 19416-21.
26. Chahrour, M., et al., MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 2008. 320(5880): 1224-9.
27. Urdinguio, R.G., et al.,Mecp2-nullmice provide newneuronal targets for Rett syndrome. PLoS One, 2008. 3(11): e3669.
28. Yakabe, S., et al., MeCP2 knockdown reveals DNA methylation-independent gene repression of target genes in living cells and a bias in the cellular location of target gene products. Genes Genet Syst, 2008. 83(2): 199-208.
29. Smrt, R.D., et al., Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis, 2007. 27(1): 77-89.
30. Yu, F., et al., Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res, 2001. 29(21): 4493-501.
31. Muotri, A.R., et al., L1 retrotransposition in neurons is modulated by MeCP2. Nature, 2010. 468(7322): 443-6.
32. Saxena, A. and P. Carninci, Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs. Bioessays, 2011. 33(11): 830-9.
33. Chow, J.C., et al., LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell, 2010. 141(6): 956-69.
34. Djebali S, et al., Landscape of transcription in human cells. Nature, 2012. doi:10.1038/nature11233.
35. Baillie, J.K., et al., Somatic retrotransposition alters the genetic landscape of the human brain. Nature, 2011. 479(7374): 534-7.
36. Slotkin, R.K. and R. Martienssen, Transposable elements and the epigenetic regulation of the genome. Nat Rev Genet, 2007. 8(4): 272-85.
37. Yang, N. and H.H. Kazazian, Jr., L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol, 2006. 13(9): 763-71.
38. Watanabe, T., et al., Endogenous siRNAs from naturally formed dsRNAs regulate transcripts inmouse oocytes. Nature, 2008. 453(7194): 539-43.
39. Aravin, A., et al., A novel class of small RNAs bind to MILI protein in mouse testes. Nature, 2006. 442(7099): 203-7.
40. Girard, A., et al., A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature, 2006. 442 (7099): 199-202.
41. Chen, L., et al., Naturally occurring endo-siRNA silences LINE-1 retrotransposons in human cells through DNA methylation. Epigenetics, 2012. 7(7): 758-71.
42. Reuter, M., et al., Miwi catalysis is required for piRNA amplification-independent LINE1 transposon silencing. Nature, 2011. 480(7376): 264-7.
43. Watanabe, T., et al., Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science, 2011. 332(6031): 848-52.
44. Brennecke, J., et al., Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell, 2007. 128(6): 1089-103.
45. Gunawardane, L.S., et al., A slicer-mediated mechanism for repeat-associated siRNA 5' end formation in Drosophila. Science, 2007. 315(5818): 1587-90.
46. Lee, E.J., et al., Identification of piRNAs in the central nervous system. RNA, 2011. 17(6): 1090-9.
47. Wu, H., et al., Genome-wide analysis reveals methyl-CpGbinding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc Natl Acad Sci USA, 2010. 107(42): 18161-6.
48. Bu, D., et al., NONCODE v3.0: integrative annotation of long noncoding RNAs.Nucleic Acids Res, 2012. 40 (Database issue): D210-5.
49. David, M., et al., SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics, 2011. 27(7): 1011-2.
50. Belichenko, P.V., et al., Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol, 2009. 514(3): 240-58.
51. Chapleau, C.A., et al., Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis, 2009. 35(2): 219-33.
52. Wang, K., et al., Export of microRNAs and microRNAprotective protein by mammalian cells. Nucleic Acids Res, 2010. 38(20): 7248-59.
53. Turchinovich, A., et al., Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011. 39(16): 7223-33.
54. Saxena, A., et al., Trehalose-enhanced isolation of neuronal sub-types from adultmouse brain. Biotechniques, 2012. 52(6): 381-5.